Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder

References

• Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012;122:3387–3393.
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics 2012;13:1149–1160.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Epigenetic mechanisms of drug addiction. Neuropharmacology 2014;76 Pt B:259–268.
   PubMed Web of Science ®Google Scholar
• Feng J, Nestler EJ. Epigenetic mechanisms of drug addiction. Curr Opin Neurobiol 2013;23:521–528.
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33:245–254.
   PubMed Web of Science ®Google Scholar
• Antequera F, Bird A. Number of CpG islands and genes in human and mouse. PNAS 1993;90:11995–11999.
   PubMed Web of Science ®Google Scholar
• Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011;12:623–637.
   PubMed Web of Science ®Google Scholar
• Wang Y, Leung FC. An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 2004;20:1170–1177.
   PubMed Web of Science ®Google Scholar
• Derks S, Lentjes MH, Hellebrekers DM, de Bruïne AP, Herman JG, van Engeland M. Methylation-specific PCR unraveled. Anal Cell Pathol 2004;26:291–299.
   Google Scholar
• Douet V, Heller MB, Le Saux O. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem Biophys Res Commun 2007;354:66–71.
   PubMed Web of Science ®Google Scholar
• Michelotti GA, Brinkley DM, Morris DP, Smith MP, Louie RJ, Schwinn DA. Epigenetic regulation of human α1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation. FASEB J 2007;21:1979–1993.
   PubMed Web of Science ®Google Scholar
• Hwang CK, Kim CS, Kim DK, Law PY, Wei LN, Loh HH. Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol 2010;78:58–68.
   PubMed Web of Science ®Google Scholar
• Hwang CK, Song KY, Kim CS, Choi HS, Guo XH, Law PY, et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol 2007;27:4720–4736.
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Yuferov V, Hamon S, Jackson C, Ho A, Ott J, et al. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacol. 2009;34:867–873.
   PubMed Web of Science ®Google Scholar
• Chorbov VM, Todorov AA, Lynskey MT, Cicero TJ. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. J Opioid Manage 2011;7:258–264.
   PubMedGoogle Scholar
• Philibert RA, Beach SR, Gunter TD, Brody GH, Madan A, Gerrard M. The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet Part B. 2010;153:619–628.
   Web of Science ®Google Scholar
• Launay J-M, Del Pino M, Chironi G, Callebert J, Peoc’h K, Mégnien J-L, et al. Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PloS One 2009;4:e7959.
   PubMed Web of Science ®Google Scholar
• Martini L, Whistler JL. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 2007;17:556–564.
   PubMed Web of Science ®Google Scholar
• Clarke T-K, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O’Brien CP, et al. Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neurosci Lett 2013;542:71–75.
   PubMed Web of Science ®Google Scholar
• Bergen A, Kokoszka J, Peterson R, Long J, Virkkunen M, Linnoila M, et al. u opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 1997;2:490–494.
   PubMed Web of Science ®Google Scholar
• Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. PNAS 1998;95:9608–9613.
   PubMed Web of Science ®Google Scholar
• Marini V, Fucile C, Zuccoli ML, Testino G, Sumberaz A, Robbiano L, et al. Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients. Addictive behaviors. 2013;38:1669–1671.
   PubMed Web of Science ®Google Scholar
• Woodcock EA, Lundahl LH, Burmeister M, Greenwald MK. Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: apilot study. Am J Addictions. 2015;24:329–335.
   PubMed Web of Science ®Google Scholar
• Ali SM, Mahnaz S, Mahmood T. Rapid genomic DNA extraction (RGDE). Forensic Sci Int: Genet Suppl Ser 2008;1:63–65.
   Google Scholar
• Tiwari S, Manoj G, Prasanth K, Sivaram G, Sharma V, Habeeb M, et al. Simplified and versatile method for bisulfite‐based DNA methylation analysis of small amounts of DNA. J Clin Lab Anal 2009;23:172–174.
   PubMed Web of Science ®Google Scholar
• Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954–5958.
   PubMed Web of Science ®Google Scholar
• Ku J-L, Jeon Y-K, Park J-G. Methylation-specific PCR. Epigenetics Protoc 2011;791:23–32.
   Google Scholar
• Zhang H, Herman AI, Kranzler HR, Anton RF, Simen AA, Gelernter J. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet 2012;57:670–675.
   PubMed Web of Science ®Google Scholar
• Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr 2014;165:472–478.
   PubMed Web of Science ®Google Scholar
• Chen H-C, Wei L-N, Loh H. Expression of μ-, κ-and δ-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience 1999;92:1143–1155.
   PubMed Web of Science ®Google Scholar
• Zhou X-L, Yu L-N, Wang Y, Tang L-H, Peng Y-N, Cao J-L, et al. Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain. Mol Pain 2014;10:1.
   PubMed Web of Science ®Google Scholar
• Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, et al. Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction. Cancer Res 1998;58:2515–2519.
   PubMed Web of Science ®Google Scholar
• Doehring A, Oertel BG, Sittl R, Lotsch J. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain. Pain 2013;154:15–23.
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Hamon S, Yuferov V, Jackson C, Ho A, Ott J, et al. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet 2010;127:639–649.
   PubMed Web of Science ®Google Scholar
• Durcova-Hills G, Burgoyne P, McLaren A. Analysis of sex differences in EGC imprinting. Dev Biol 2004;268:105–110.
   PubMed Web of Science ®Google Scholar
• El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007;122:505–514.
   PubMed Web of Science ®Google Scholar
• Sarter B, Long TI, Tsong WH, Koh W-P, Mimi CY, Laird PW. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 2005;117:402–403.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Teicher MH. Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuse. Neurosci Biobehavioral Rev 2009;33:516–524.
   PubMed Web of Science ®Google Scholar
• Chen CC, Wang KY, Shen CK. DNA 5-methylcytosine demethylation activities of the mammalian DNA methyltransferases. J Biol Chem 2013;288:9084–9091.
   PubMed Web of Science ®Google Scholar
• Ninković J, Roy S. Role of the mu-opioid receptor in opioid modulation of immune function. Amino acids. 2013;45:9–24.
   PubMed Web of Science ®Google Scholar